Investing Profile

Sebastian Kreuz

InvestorVC
Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim
Photo of Sebastian Kreuz, Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Boehringer Ingelheim Network
17 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
smartbax
SeedOct 2025$5M
SeedMay 2023$1M
$6M
Centauri Therapeutics
Series AFeb 2022$33M
$33M
Co-investors: Johannes Zanzinger (Boehringer Ingelheim Venture Fund)
Postdoctoral Researcher (Functional Genomics) Boehringer IngelheimPresent
Laboratory Head (Target Discovery Research) Boehringer IngelheimPresent
Project Leader (Immunology & Respiratory Diseases Research) Boehringer IngelheimPresent
Associate Director (Research Beyond Borders) Boehringer IngelheimPresent
Executive Director / Investment Manager (BI Venture Fund) Boehringer IngelheimPresent
Head of Boehringer Ingelheim Venture Fund EU Boehringer IngelheimPresent